Pediatrix Medical Group (NYSE:MD – Free Report) had its price target decreased by Truist Financial from $10.50 to $10.00 in a research note issued to investors on Wednesday, Benzinga reports. Truist Financial currently has a hold rating on the stock. Separately, UBS Group began coverage on shares of Pediatrix Medical Group in a research report […]